News | March 10, 2008

MITA Thanks Congress for CCTA Coverage Plea to CMS

March 10, 2008 – The Medical Imaging & Technology Alliance (MITA), a division of NEMA, today praised the 88 Members of Congress who urged the Centers for Medicare & Medicaid Services (CMS) to reconsider its proposed national coverage decision (NCD) that will limit patient access to cardiac computed tomography angiography (CCTA).

Representatives Baldwin, Buyer, Camp, Cramer, Green (Gene), McCarthy (Carolyn), Myrick, Pitts, Walsh, Whitfield, Wilson (Heather) and Senators Shelby and Voinovich wrote individual letters to CMS.
After weighing-in individually, Reps. McCarthy, Pitts and Green also coordinated a Dear Colleague letter to CMS. This move garnered signatures from 78 Members of Congress, including:

Alexander, Allen, Berman, Bilirakis, Blackburn, Boswell, Boustany, Butterfield, Capps, Capuano, Castle, Conaway, Cubin, Cummings, Delahunt, English, Ferguson, Fossella, Frank, Gerlach, Gilchrest, Gonzalez, Green (Al), Green (Gene), Hall (Ralph), Herger, Higgins, Hodes, Hulshof, Inglis, Inslee, Jefferson, Kagen King (Peter), Kirk, Kuhl, Larsen, LaTourette, LoBiondo, Lowey, Maloney, Marchant, Matheson McCarthy (Carolyn), McCarthy (Kevin), McGovern, McNulty, Meek, Michaud, Moore (Dennis), Murphy (Christopher), Neal, Neugebauer, Olver, Ortiz, Pascrell, Paul, Pickering, Pitts, Porter, Price, (Tom), Rahall, Reyes, Rogers (Mike-MI), Roskam, Ruppersberger, Scott (Bobby), Sessions, Shimkus, Souder, Sutton, Tanner, Tierney, Towns, Tsongas, Walberg, Wamp, and Wilson (Charles).

“CCTA is an extremely important medical imaging tool that detects Coronary Artery Disease (CAD) within seconds, eliminating the need for surgery or catheterization,” said Andrew Whitman, Vice President, MITA. “MITA applauds the Members of Congress who recognize that CCTA has revolutionized the way doctors diagnose heart disease and who are questioning CMS’ proposed decision to eliminate CCTA coverage.”

According to the National Institutes of Health, CAD is the most common type of heart disease—and the number one killer for both men and women. Based on existing evidence and clinical analysis, CCTA has widespread acceptance as a proven technology that rules out heart disease with greater than 99 percent accuracy, while avoiding the high costs of more invasive and expensive procedures. As a result, CCTA is used in more than 2,000 centers nationwide and has been approved by local Medicare carriers in all 50 states.

“CCTA has become the standard of care for cardiac disease throughout the country and the world,” said Whitman. “MITA is proud to work with Members of Congress and others to ensure that patients have coverage for this important test. It is our hope that CMS will permit continued access to this state-of-the-art diagnostic tool for heart disease patients nationwide.”

For more information:

Related Content

Siemens Healthineers, Florida Hospital Collaborate to Improve Healthcare Outcomes
News | CT Angiography (CTA) | January 23, 2018
January 23, 2018 – Siemens Healthineers and Florida Hospital, part of Adventist Health System, have announced a multi
Videos | CT Angiography (CTA) | July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
Videos | CT Angiography (CTA) | July 18, 2017
Matthew Budoff, M.D., FACC, professor of medicine, David Geffen School of Medicine at UCLA, endowed chair of preventi
FFR-CT, heartflow

An example of an FFR-CT image, showing the FFR values for all coronary vessel segments and the reduction in hemodynamic flow after specific lesions.

News | CT Angiography (CTA) | July 12, 2017
July 12, 2017 — The American Medical Association (AMA) has granted a Category III Tracking Code for estimated coronar
Videos | CT Angiography (CTA) | July 10, 2017
David Bluemke, M.D., Ph.D., FAHA, professor of radiology, University of Wisconsin - Madison, incoming editor of RSNA’
Heartflow FFR-CT can noninvasively assess the hemodynamic impact of coronary lesions to avoid the need for an invasive angiogram.

HeartFlow FFR-CT can noninvasively assess the hemodynamic impact of coronary lesions to avoid the need for an invasive angiogram.

Technology | CT Angiography (CTA) | July 06, 2017
July 6, 2017 — GE Healthcare and HeartFlow Inc.
cardiac CT showing a severe right coronary artery lesion on a Toshiba Aquillion One

A cardiac CT showing a severe right coronary artery lesion on both 3-D and curved multiplanar reconstructions from a Toshiba Aquilion One CT system. The newest generation of CT scanners have very fast gantry speeds to freeze cardiac motion, improved image quality and much lower doses than previous generation scanners from a decade ago.

Feature | CT Angiography (CTA) | April 13, 2017 | Dave Fornell
Cardiac computed tomography (CT) imaging really took off a decade ago with the introduction of 64-slice scanners, whi
CTA, CT angiography, predict heart attacks, Radiology study
News | CT Angiography (CTA) | March 14, 2017
Noninvasive computed tomography (CT) angiography and stress tests can help predict which patients are likely to suffer...
HeartFlow FFRct Analysis, NICE guidance, U.K., United Kingdom, guidelines, stable chest pain
News | CT Angiography (CTA) | February 14, 2017
The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued guidance for use of...
Overlay Init